MarketPeel
Insider Trading Intelligence
LW

Leana Wen

GKOS
DIRECTOR · GLAUKOS CORP · CIK 0001847598
FILING MIX · LIFETIME93%/7%
BUYS
25
SELLS
2
TOTAL VALUE
$243.7K
COMPANIES
2
ACTIVE SINCE
Mar 2021
HOLDINGS NOW
31,617
AVG SELL PX
$143.35
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Leana Wen, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-4.78%+2.35%-7.13%-7.13%
14d1+100.00%-1.08%+3.01%-4.08%-4.08%
30d1+100.00%-26.29%
60d1+0.00%+3.00%+2.82%+0.17%+0.17%
90d1(1 pending)
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GKOS · 21,617 shares · as of May 28, 2026
05,40410,80916,21321,61720222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 2 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,00010,000Jun 22, 2026Jun 23, 2026View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
8,0008,000Jun 22, 2026Jun 23, 2026View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,87821,617May 28, 2026Jun 1, 2026View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,9872,987May 28, 2026Jun 1, 2026View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,9872,987May 28, 2026Jun 23, 2026View →
GKOS
GLAUKOS CORP
SALE
1,700$143.35$243.7K19,739May 1, 2026May 4, 2026View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
62321,439Jan 2, 2026Jan 7, 2026View →
URGN
UROGEN PHARMA LTD.
SALE
2,0006,000Nov 26, 2025Dec 1, 2025View →
URGN
UROGEN PHARMA LTD.
PURCHASE
2,0002,000Nov 26, 2025Dec 1, 2025View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,00010,000Aug 26, 2025Aug 27, 2025View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
8,0008,000Aug 26, 2025Aug 27, 2025View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
3,1493,149May 29, 2025Jun 2, 2025View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,10820,816May 29, 2025Jun 2, 2025View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
46118,708Jan 2, 2025Jun 2, 2025View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,00010,000Aug 6, 2024Aug 7, 2024View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,71618,247May 30, 2024Jun 3, 2024View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,2461,246May 30, 2024Jun 3, 2024View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,00010,000Sep 7, 2023Sep 8, 2023View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
3,23016,531Jun 1, 2023Jun 5, 2023View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,57213,301Jan 3, 2023Jan 4, 2023View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,57213,301Jan 3, 2023Jan 4, 2023View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
20,00020,000Sep 8, 2022Sep 12, 2022View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
4,36411,729Jun 2, 2022Jun 6, 2022View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,4557,365Jan 3, 2022Jan 5, 2022View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,3825,910Jun 3, 2021Jun 7, 2021View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
4493,528Mar 1, 2021Mar 3, 2021View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
3,0793,079Mar 1, 2021Mar 3, 2021View →
Other insiders · GKOS
Loading peer insiders…
About this filer
CIK 0001847598
ROLE
Director
PRIMARY
GKOS
COMPANIES
2
ACTIVE SINCE
Mar 2021
MARKETPEEL · /INSIDER/0001847598DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback